Article Contents ::

Details About Generic Salt ::  Azithrom

Main Medicine Class:: Antibiotic, Macrolide   

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

 

Drugs Class ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Indications for Drugs ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Dose ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Contraindication ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Precautions ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Side Effects ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Mode of Action ::  

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Interactions ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

Drug Assesment ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Storage/Management ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Drug Notes ::

(UHZ-ith-row-MY-sin)
Zithromax
Tablets: 250 mg (as dihydrate)
Tablets: 500 mg (as dihydrate)
Tablets: 600 mg (as dihydrate)
Powder for injection, lyophilized: 500 mg
Powder for oral suspension: 100 mg/5 mL
Powder for oral suspension: 200 mg/5 mL
Powder for oral suspension: 1 g/packet (as dihydrate)
Class: Antibiotic, Macrolide

 

 Action Interferes with microbial protein synthesis.

 

 Indications

ADULTS: Treatment of infections of the respiratory tract, chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, Mycobacterium avium complex, pelvic inflammatory disease, skin and skin structure, and sexually-transmitted diseases caused by susceptible organisms.

CHILDREN: Treatment of acute otitis media caused by susceptible organisms; community-acquired pneumonia, treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.

 

 Contraindications Hypersensitivity to azithromycin, erythromycin, or to any macrolide antibiotic.

 

 Route/Dosage

Acute Otitis Media

Children 6 mo and older: PO 30 mg/kg given as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day) followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Bacterial Infections

Adults: PO 500 mg as single dose on first day, then 250 mg/day on days 2 through 5.

Community-Acquired Pneumonia

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Adults: IV 500 mg as a single daily dose for greater than or equal to 2 days. Follow IV therapy by the oral route at a single daily dose of 500 mg to complete 7- to 10-day course of therapy.

Children 6 mo and older: PO 10 mg/kg as a single dose on the first day (not to exceed 500 mg/day), followed by 5 mg/kg on days 2 through 5 (not to exceed 250 mg/day).

Gonorrhea

Adults: PO Single 2 g dose.

Mild to Moderate COPD

Adults and children 16 yr and older: PO 500 mg/day for 3 days or 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Mycobacterium Avium Complex

Adults: PO Prevention: 1.2 g taken weekly. Treatment: 600 mg/day in combination with ethambutol (15 mg/kg).

Pelvic Inflammatory Disease

Adults: IV 500 mg as a single daily dose for 1 to 2 days. Follow IV therapy by the oral route at a single daily dose of 250 mg to complete a 7-day course of therapy.

Pharyngitis/Tonsillitis

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily on days 2 through 5.

Children at least 2 yr: PO 12 mg/kg/day for 5 days, not to exceed 500 mg/day.

Genital Ulcer Disease caused by H. ducreyi (chancroid), Nongonococcal Urethritis/Cervicitis caused by C. trachomatis:

Adults: PO Single 1 g dose.

Uncomplicated Skin and Skin Structure Infections

Adults and children 16 yr and older: PO 500 mg as a single dose on the first day followed by 250 mg once daily for 4 days.

 

 Interactions

HMG-CoA reductase inhibitors (eg, lovastatin):

Increased risk of myopathy and rhabdomyolysis.

Tacrolimus:

Increased tacrolimus plasma levels with increased risk of toxicity.

Warfarin:

The anticoagulant effect may be increased, increasing the risk of hemorrhage.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions

CARDIOVASCULAR: Palpitations; chest pain. CNS: Dizziness; headache; vertigo; somnolence; fatigue. DERMATOLOGIC: Rash; photosensitivity. GI: Diarrhea; nausea; vomiting; abdominal pain; dyspepsia; flatulence; melena. GU: Vaginitis; monilia; nephritis. HEPATIC: Cholestatic jaundice. OTHER: Angioedema; anaphylaxis.

 

 Precautions

Pregnancy: Category B. Lactation: Undetermined. Cardiac effects: Serious cardiovascular events have occurred with other macrolide antibiotics, especially when given concomitantly with certain antihistamines (eg, terfenadine). Gonorrhea/Syphilis: Ineffective for treatment of these infections. Hepatic/Renal function impairment: Use cautiously. Pneumonia: Only effective for mild community-acquired pneumonia. Pseudomembranous colitis: May be factor in patients who develop diarrhea.

PATIENT CARE CONSIDERATIONS


 

 Administration/Storage

Oral suspension/Tablets

  • Administer 1 hr before or 2 hr after meal.
  • Tablets can be taken without regard to meals.
  • Time doses evenly throughout day for optimal blood levels.
  • Do not give antacids for greater than 2 hr after administration of product.
  • Do not crush capsules.
  • Give patient 6 to 8 oz of water or noncitrus juice with oral medication.
  • Store reconstituted oral suspension at room temperature and use within 10 days. Discard after full dosing is completed.
  • Store in tightly closed container at room temperature.

Injection

  • The infusate concentration and rate of infusion for azithromycin for injection should be either 1 mg/mL over 3 hr or 2 mg/mL over 1 hr. Do not administer as a bolus or IM injection.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Review C&S report as available.
  • Monitor renal, liver, and GI function during therapy. Notify health care provider of any GI side effects.
  • Observe for signs of superinfection during therapy (eg, yeast infections, black hairy tongue, itching in groin area).
  • Monitor for bleeding in patients receiving concomitant oral anticoagulant therapy.
  • Notify health care provider if signs and symptoms of anaphylaxis occur.

 

 Patient/Family Education

  • Instruct patient to time doses for even distribution over a 24-hr period.
  • Inform patient that the medication works best on empty stomach, but may be taken with food if there is GI upset.
  • Instruct patient to take medication with full glass of water or noncitrus juice.
  • Encourage patient to increase fluid intake to 2000 to 3000 mL/day, if not contraindicated.
  • Instruct patient to notify health care provider if rash develops or difficult breathing occurs.
  • Explain that antacids should be avoided while this medication is being taken.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.